TRUBRIDGE INC (TBRG) Stock Fundamental Analysis
NASDAQ:TBRG - Nasdaq - US2053061030 - Common Stock - Currency: USD
Overall TBRG gets a fundamental rating of 4 out of 10. We evaluated TBRG against 37 industry peers in the Health Care Technology industry. TBRG has a medium profitability rating, but doesn't score so well on its financial health evaluation. TBRG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TBRG was profitable.
TBRG had a positive operating cash flow in the past year.
In multiple years TBRG reported negative net income over the last 5 years.
Each year in the past 5 years TBRG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.61%, TBRG is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of -13.11%, TBRG is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
TBRG's Return On Invested Capital of 1.20% is fine compared to the rest of the industry. TBRG outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.61% | ||
| ROE | -13.11% | ||
| ROIC | 1.2% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 1.22%, TBRG is doing good in the industry, outperforming 75.68% of the companies in the same industry.
In the last couple of years the Operating Margin of TBRG has declined.
TBRG has a Gross Margin (50.62%) which is in line with its industry peers.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.22% | ||
| PM (TTM) | N/A | ||
| GM | 50.62% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
TBRG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TBRG has been increased compared to 1 year ago.
TBRG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TBRG has an improved debt to assets ratio.
2.2 Solvency
TBRG has an Altman-Z score of 2.19. This is not the best score and indicates that TBRG is in the grey zone with still only limited risk for bankruptcy at the moment.
TBRG has a better Altman-Z score (2.19) than 67.57% of its industry peers.
The Debt to FCF ratio of TBRG is 13.20, which is on the high side as it means it would take TBRG, 13.20 years of fcf income to pay off all of its debts.
TBRG has a Debt to FCF ratio of 13.20. This is comparable to the rest of the industry: TBRG outperforms 56.76% of its industry peers.
A Debt/Equity ratio of 1.00 indicates that TBRG is somewhat dependend on debt financing.
The Debt to Equity ratio of TBRG (1.00) is worse than 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 13.2 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.11
WACC11.03%
2.3 Liquidity
TBRG has a Current Ratio of 1.70. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Current ratio of 1.70. This is comparable to the rest of the industry: TBRG outperforms 51.35% of its industry peers.
TBRG has a Quick Ratio of 1.69. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Quick ratio (1.69) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The earnings per share for TBRG have decreased strongly by -89.39% in the last year.
TBRG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.46% yearly.
TBRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.47%.
Measured over the past years, TBRG shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)-89.39%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%-86.11%
Revenue 1Y (TTM)25.47%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.74%
3.2 Future
The Earnings Per Share is expected to grow by 206.51% on average over the next years. This is a very strong growth
Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 5.33% on average per year.
EPS Next Y635.47%
EPS Next 2Y206.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.86%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 133.42, TBRG can be considered very expensive at the moment.
Based on the Price/Earnings ratio, TBRG is valued a bit cheaper than the industry average as 70.27% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.78, TBRG is valued quite expensively.
With a Price/Forward Earnings ratio of 18.14, TBRG is valued on the expensive side.
89.19% of the companies in the same industry are more expensive than TBRG, based on the Price/Forward Earnings ratio.
TBRG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 133.42 | ||
| Fwd PE | 18.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 81.08% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TBRG is valued cheaper than 86.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.17 | ||
| EV/EBITDA | 15.76 |
4.3 Compensation for Growth
TBRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TBRG's earnings are expected to grow with 206.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y206.51%
EPS Next 3YN/A
5. Dividend
5.1 Amount
TBRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
25.35
-0.25 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners74.28%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner Change12.26%
Market Cap378.98M
Analysts78.18
Price Target29.84 (17.71%)
Short Float %4.53%
Short Ratio2.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.78%
Min EPS beat(2)-176.25%
Max EPS beat(2)-87.3%
EPS beat(4)1
Avg EPS beat(4)-61.77%
Min EPS beat(4)-176.25%
Max EPS beat(4)24.18%
EPS beat(8)3
Avg EPS beat(8)-36.59%
EPS beat(12)5
Avg EPS beat(12)-24.75%
EPS beat(16)8
Avg EPS beat(16)-14.99%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.02%
Min Revenue beat(4)-1.68%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-1.22%
Revenue beat(12)4
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)10.8%
PT rev (3m)58.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)29.04%
EPS NY rev (1m)-3.11%
EPS NY rev (3m)-14.11%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 133.42 | ||
| Fwd PE | 18.14 | ||
| P/S | 0.89 | ||
| P/FCF | 29.17 | ||
| P/OCF | 11.81 | ||
| P/B | 2.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.76 |
EPS(TTM)0.19
EY0.75%
EPS(NY)1.4
Fwd EY5.51%
FCF(TTM)0.87
FCFY3.43%
OCF(TTM)2.15
OCFY8.47%
SpS28.49
BVpS11.28
TBVpS-8.16
PEG (NY)0.21
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.61% | ||
| ROE | -13.11% | ||
| ROCE | 1.52% | ||
| ROIC | 1.2% | ||
| ROICexc | 1.24% | ||
| ROICexgc | 10.66% | ||
| OM | 1.22% | ||
| PM (TTM) | N/A | ||
| GM | 50.62% | ||
| FCFM | 3.05% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-34.77%
ROICexcg growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score7
Asset Turnover1.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 13.2 | ||
| Debt/EBITDA | 4.94 | ||
| Cap/Depr | 65.92% | ||
| Cap/Sales | 4.48% | ||
| Interest Coverage | 0.32 | ||
| Cash Conversion | 93.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 2.19 |
F-Score7
WACC11.03%
ROIC/WACC0.11
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.39%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%-86.11%
EPS Next Y635.47%
EPS Next 2Y206.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.47%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.74%
Revenue Next Year4.86%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y219.12%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year147.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y158.15%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y2930.59%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%